The images are shown for illustration purposes only. They may not be an exact representation of the product.
Tirzepatide/Leucine/Pyridoxine is a compounded injectable formulation that may be considered for patients with specific prescribing needs. This combination supports individualized dosing schedules, including smaller, more frequent injections as part of a GLP-1 microdosing protocol when clinically appropriate.
The formulation is supplied in multi-dose vials for subcutaneous injection. Updated stability data allows refrigerated storage without freezing. Each prescription includes syringes, alcohol swabs, and a patient information guide.
Available Strength: 20 mg/10 mg/10 mg per mL
A valid patient-specific prescription is required. Compounded medications are not FDA-approved. Dosing and administration are determined by the prescribing healthcare provider.
